S&P TSX Capped Composite...

US Dollar vs CAD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

ZNTL Zentalis Pharmaceuticals Inc

12.54

0.02 (0.16%)

May 10 2024 - Closed

Delayed by 15 minutes

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Article too big to display. Click here to view on the SEC website

Zentalis Pharmaceuticals (NASDAQ:ZNTL)
Historical Stock Chart
From Apr 2024 to May 2024

Click Here for more Zentalis Pharmaceuticals Charts.

Zentalis Pharmaceuticals (NASDAQ:ZNTL)
Historical Stock Chart
From May 2023 to May 2024

Click Here for more Zentalis Pharmaceuticals Charts.

Zentalis Pharmaceuticals Inc News

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Tuesday 7 May 2024 (5 days ago) • Edgar (US Regulatory)

Form 8-K - Current report
Tuesday 7 May 2024 (5 days ago) • Edgar (US Regulatory)

Zentalis Pharmaceuticals Reports First Quarter 2024 Financial Results and Operational Progress
Tuesday 7 May 2024 (5 days ago) • GlobeNewswire Inc.

Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Wednesday 1 May 2024 (2 weeks ago) • GlobeNewswire Inc.

Zentalis Pharmaceuticals to Highlight Preclinical Data Demonstrating that WEE1 Inhibitor Azenosertib Exerts Synergistic Anti-tumor Activity with KRAS(G12C) Inhibitors at AACR Annual Meeting 2024
Tuesday 2 April 2024 (1 month ago) • GlobeNewswire Inc.

Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Monday 1 April 2024 (1 month ago) • GlobeNewswire Inc.

Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Friday 1 March 2024 (2 months ago) • GlobeNewswire Inc.

Form S-8 - Securities to be offered to employees in employee benefit plans
Thursday 29 February 2024 (2 months ago) • Edgar (US Regulatory)

Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers
Thursday 29 February 2024 (2 months ago) • Edgar (US Regulatory)

Zentalis Pharmaceuticals to Participate in Upcoming Investor Conferences
Wednesday 28 February 2024 (2 months ago) • GlobeNewswire Inc.

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Tuesday 27 February 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Tuesday 27 February 2024 (2 months ago) • Edgar (US Regulatory)

More Zentalis Pharmaceuticals Inc News Articles

Registry Direct

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions